ALSA Ventures — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
Presage Biosciencespresagebio.comAug 2015
Presage Biosciences is a translational oncology company that operates the CIVO (Comparative In Vivo Oncology) platform, a patented intratumoral drug delivery and analysis technology for evaluating how tumors respond to multiple investigational treatments.
BiotechDeep TechHealthtech
Univercells’s websiteunivercells.comOct 2015 · $3M
Co-investorsAdBio partnersGlobal Health Investment CorporationIn-Q-Tel
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.